Following a break due to the pandemic, our annual Investment Day is back! And what’s more, after ten years of hosting the event in Stockholm at ‘Västerbottensdagarna på Grand’, we’re bringing it back to Umeå again!

2023, the event takes place in the heart of the city at Rex at Rådhustorget, from 10 am to 5 pm on Tuesday, May 9th.

It promises to be an exciting day of partnering between life science startups from the Västerbotten region and regional, national, and international investors.

The program

Around 30 investors and 30 entrepreneurs usually participate in the UBI Investment Day – with partnering sessions lasting approximately 25 minutes.

Important links

Registration for investors (last registration date April 27)
Registration for participating companies
Important information for participating companies

If you have any questions, please contact:
Pia Keyser, pia.keyser@ubi.se, 0046-(0)73-620 51 61

Participating companies and partnering

The following companies have currently registered to participate. More non-confidential information about these companies will be presented on this page later this spring. (At the beginning of April you will be sent a link and an invitation to select the companies you would like to meet during our partnering sessions).

Registered Companies

Brain Stimulation AB
Area: Medtech/E-health/Diagnostics
Onepager: BrainStimulation Onepager
Website: brainstimulation.se

Cropcision AB
Area: AgTech (Agriculture, Forestry & Horticulture)
Project owner: Jonathan Love.
Incubator phase: Preincubator/External field trials
Onepager: Cropcision Onepager
Website: ubi.se/case/cropcision-precision-fertilizer-technology-for-farms-forests-and-greenhouses/

Development of a small chemical compound to target Epstein-Barr Virus associated diseases
Area: Drug development
Project owner: Robin Fåhraeus.
Incubator phase: Verify/R&D
Onepager: EBVc_Onepager
Website: www.ubi.se/case/development-of-a-small-chemical-compound-to-target-epstein-barr-virus-associated-diseases/

HiloProbe 
Area: Diagnostics
Onepager: Hiloprobe Onepager
Website: hiloprobe.se

Lipigon Pharmaceuticals
Area: Drug development
Website: lipigon.se

LIPUM AB
Area: Drug development
Website: lipum.se

Lyfe Therapeutics (Liver fibrosis treatment candidate)
Area: Drug development
Incubator phase: Verify/R&D
Onepager: Lyfe Therapeutics_Onepager
Website: https://www.ubi.se/case/lyfe-therapeutics-a-new-therapy-for-chronic-liver-inflammation-and-fibrosis/

MetaCurUm Biotech AB
Area: Drug development
Onepager: MetaCurUm Biotech onepager
Website: metacurum.se

NanoBio Select@
Area: Medtech
Project owner: Thomas Wågberg and Xueen Jia.
Incubator phase: Verify/R&D
Onepager: NanoBio Select@
Website: www.ubi.se/case/nanobio-select-to-advance-precision-immunoassay-with-a-combination-of-nano-and-biotechnologies/

Neores 
Area: Medtech
Project owner: Thomas Drevhammar.
Incubator phase: Grow
Onepager: Neores Onepager
Website: www.ubi.se/case/neores-improving-neonatal-resuscitation-and-ventilation

Novel molecules for efficient photodynamic therapy
Area: Drug development.
Project owner: Nasim Sabouri
Incubator phase: Preincubator/R&D
One-pager: PDT Onepager
Website: www.ubi.se/case/novel-molecules-for-efficient-photodynamic-therapy/

Phenotype Diagnostics 
Area: InVitro Diagnostic.
Project owner: Pernilla Wikström, Elin Thysell och Anders Bergh.
Incubator phase: Finance.
Onepager: Phenotype Diagnostics
Website: www.ubi.se/case/novel-method-for-risk-assessment-and-treatment-stratification-in-men-with-prostate-cancer/

QureTech Bio AB
Area: Drug development
Onepager: QureTechBio
Website: quretech.com

Vakona
Area: Drug development
One-pager: Vakona onepager
Website: vakona.se